CREXONT
Active substance: CARBIDOPA HYDRATE, LEVODOPA
CAPSULE, EXTENDED RELEASE · CARBIDOPA HYDRATE 87.5 mg/1, LEVODOPA 350 mg/1
United StatesActive
Marketing holder: Amneal Pharmaceuticals LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- CARBIDOPA HYDRATE · 87.5 mg/1
- LEVODOPA · 350 mg/1
Registration
- Registration number
- 64896-970
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 64896-970 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 64896-970 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 64896-970 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 64896-970 · Verified 2026-10-09 · open in source